Severity
Moderate
ModerateClass IITerminated
FDA Food recall · Reported July 26, 2017
GnuPharma Relief 100% Herbal Supplement 60 Capsules
1 ingredient failed identity testing and 2 ingredients failed microbiological testing (E.coli)
Compiled from official public sources by the editorial team.
Verify with FDA Food →
GnuPharma Corp. recalled GnuPharma Relief 100% Herbal Supplement 60 Capsules - a moderate-severity action.
GnuPharma Relief 100% Herbal Supplement 60 Capsules was recalled by GnuPharma Corp. in July 26, 2017. Reason: 1 ingredient failed identity testing and 2 ingredients failed microbiological testing (E.coli). Check the official notice for the remedy. Verify recall #F-0297-2017 with the FDA Food before acting.
The recall
GnuPharma Corp. issued this moderate-severity FDA Food recall — 1 ingredient failed identity testing and 2 ingredients failed microbiological testing (E.coli).
- Moderate
- severity level
- Class II
- classification
- July 26, 2017
- reported
Sourced from official FDA Food enforcement records. Verify recall #F-0297-2017 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
Recall Insight
This FDA Food action (record #F-0297-2017) was formally reported on July 26, 2017, with the manufacturer initiating the action on May 8, 2017. It is classified under Moderate severity (Class II), with a current status of Terminated. GnuPharma Corp. is listed as the recalling firm, operating out of Owasso, OK. Federal records list the affected scope as 244 bottles.
The documented reason for this recall is: 1 ingredient failed identity testing and 2 ingredients failed microbiological testing (E.coli) Distribution data in the federal record shows the product reached: US. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 1 from FDA Food — clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Drugs & Medications recalls over time
Where this recall sits in its category — 14,048 drugs & medications recalls on record
Where this recall sits in the database
Of 100,165 recalls in the database, 23,668 are high severity, 72,097 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Affected scope
244 bottles
Related Recalls
6
1 from same agency
Product description
GnuPharma Relief 100% Herbal Supplement 60 Capsules
Reason for recall
1 ingredient failed identity testing and 2 ingredients failed microbiological testing (E.coli)
Recall Profile
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Terminated |
| Recall number | F-0297-2017 |
| Date reported | July 26, 2017 |
| Date initiated | May 8, 2017 |
| Recalling firm | GnuPharma Corp. |
| Firm location | Owasso, OK |
| Affected scope | 244 bottles |
| Distribution | US |
Profile values are sourced directly from the official FDA Food enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
- Check the recall number (F-0297-2017) and product description against the item you own. Search the archive
- Confirm the current status with FDA Food before acting — recall details can be updated.
- Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next
This page summarizes the official FDA Food record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Frequently Asked Questions
What product was recalled? ▼
GnuPharma Relief 100% Herbal Supplement 60 Capsules. Recalled by GnuPharma Corp.. Units affected: 244 bottles.
Why was this product recalled? ▼
1 ingredient failed identity testing and 2 ingredients failed microbiological testing (E.coli)
Which agency issued this recall? ▼
This recall was issued by the FDA Food on July 26, 2017. Severity: Moderate. Recall number: F-0297-2017.
Where was the recalled product distributed? ▼
Distribution: US.
How do I check if my product is affected by a recall? ▼
Check the product description and recall number (F-0297-2017) against your product. Visit the official FDA Food website for the most current information. You can also use our Recall Checker tool to search by product name or brand.
What are the health risks of consuming a recalled food product? ▼
Recalled food products may contain contaminants, undeclared allergens, or harmful bacteria such as Salmonella, Listeria, or E. coli. Consuming these products can cause foodborne illness ranging from mild gastrointestinal symptoms to serious conditions requiring hospitalization. If you have consumed a recalled food product and experience symptoms, contact your healthcare provider and report to the FDA via MedWatch.
Continue exploring
Keep tracking product safety across the federal recall archive.
Recall Checker
Search the full archive by product name, brand, or recall number across every agency.
Check a product →
FDA Food recalls
Every recall issued by FDA Food, newest first.
Browse the feed →
RecallRadar
Live feed of the latest recalls across the FDA, CPSC and NHTSA — filter by agency and severity.
View the live feed →
Rankings
The largest recalls by units affected and the most-recalled product categories.
See the rankings →
Browse by category
Find recalls by product type to spot recurring defect patterns.
All categories →
What to do next
A step-by-step guide to refunds, repairs, and returns after a recall.
Read the guide →
Nearby Recalls in This Category
Other recalls in the same product category — useful for spotting patterns across the same defect class or manufacturer.
FDA Drug Low
Nicotine Transdermal System Patch, 14 mg, 14 patches per box, Aveva, Distributed by: RUGBY LABORATORIES, Indianapolis, …
AVEVA Drug Delivery Systems, Inc. · 2026-06-03
FDA Drug Low
PRED MILD, prednisolone acetate ophthalmic suspension, USP, 0.12%, 10 mL, Sterile, Rx only, Allergen, Inc., an AbbVie c…
AbbVie Inc. · 2026-06-03
FDA Food Moderate
Vitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement, Net Wt. 8 FL Oz (237mL) Amber PET modern round 24-400 bot…
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
FDA Drug Moderate
Atomoxetine Capsules HCL, 10 mg Capsules in unit dose foil strip, strips are packed in cartons of 100, Rx Only, Pkg by:…
Safecor Health, LLC · 2026-05-27
FDA Drug Moderate
fentaNYL Citrate, Sterile CADD for Injection, 2,2500 mcg/50mL in Sterile Water, IntegraDose Compounding Services LLC, 3…
IntegraDose Compounding Services LLC · 2026-05-27
Compare this recall with Nicotine Transdermal System Patch, 14 mg, 14 patches per bo… →
Data Sources
Source: FDA, CPSC, and NHTSA federal recall databases. This recall: FDA Food, reported July 26, 2017.
- Source: FDA — Food and Drug Administration, openFDA Enforcement API (food, drug, and medical device recalls)
- Source: CPSC — Consumer Product Safety Commission Recalls API (consumer product recalls and hazards)
- Source: NHTSA — National Highway Traffic Safety Administration Recalls API (vehicle safety recalls)
Recall information is sourced from official federal agency databases. Always verify recall details with the issuing agency for the most current status. This information is for research and awareness purposes only.
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of June 2026.